OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00689056

Taekyung Chemical Co Ltd

Commodity ChemicalsVerified

Taekyung Chemical Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.23, significantly below the industry median of 0.45. The company's liquidity position is mixed, with a strong current ratio of 4.86 but negative net cash after subtracting total debt. Free cash flow is negative at -5.84 billion KRW, driven by capital expenditures of -15.02 billion KRW. Profitability metrics show the company underperforming relative to industry benchmarks. Return on equity of 5.07% lags behind the 8.2% median for Commodity Chemicals, while return on assets of 3.9% is below the 5.6% industry median. Operating margin of 3.4% (2.08 billion KRW operating income on 61.35 billion KRW revenue) is 200 bps below the sector average. Revenue concentration analysis reveals a balanced segment structure. The carbon dioxide gas segment accounts for 52% of revenue, Environment for 31%, and Other for 17%. Geographically, 98% of revenue is derived from South Korea, with the remaining 2% from Asia-Pacific. No single customer accounts for more than 10% of revenue. Growth trajectory shows mixed signals. Current FY revenue is projected to increase by 4.2% year-over-year, but next FY guidance calls for a 1.8% decline. This follows a 3-year CAGR of 2.1% in revenue, with operating income growth at 0.7% CAGR. The slowdown in growth correlates with capital expenditures outpacing operating cash flow. Risk assessment highlights liquidity as the primary concern. The company's negative net cash position and negative free cash flow create medium liquidity risk. Dilution risk is assessed as low, with no recent share issuance and diluted shares outstanding equal to basic shares. However, the capital structure adjustment for free cash flow includes a -15% downward revision for working capital needs. Recent filings show no material changes in business strategy or risk profile. The 2023 annual report confirms continued focus on core chemical products and no new material commitments. Transcripts from Q1 2024 earnings calls emphasize cost control measures to offset raw material price volatility.

30-day price · 006890-540.00 (-6.5%)
Low$7630.00High$9290.00Close$7730.00As of22 May, 00:00 UTC
Profile
CompanyTaekyung Chemical Co Ltd
Ticker006890.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Taekyung Chemical Co Ltd is a Korea-based company engaged in the manufacture and sale of liquid carbonate, dry ice, magnesium hydroxide, and liquid slaked lime, operating through three segments: carbon dioxide gas, Environment, and Other.

Classification. Taekyung Chemical Co Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Taekyung Chemical Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.23, significantly below the industry median of 0.45. The company's liquidity position is mixed, with a strong current ratio of 4.86 but negative net cash after subtracting total debt. Free cash flow is negative at -5.84 billion KRW, driven by capital expenditures of -15.02 billion KRW. Profitability metrics show the company underperforming relative to industry benchmarks. Return on equity of 5.07% lags behind the 8.2% median for Commodity Chemicals, while return on assets of 3.9% is below the 5.6% industry median. Operating margin of 3.4% (2.08 billion KRW operating income on 61.35 billion KRW revenue) is 200 bps below the sector average. Revenue concentration analysis reveals a balanced segment structure. The carbon dioxide gas segment accounts for 52% of revenue, Environment for 31%, and Other for 17%. Geographically, 98% of revenue is derived from South Korea, with the remaining 2% from Asia-Pacific. No single customer accounts for more than 10% of revenue. Growth trajectory shows mixed signals. Current FY revenue is projected to increase by 4.2% year-over-year, but next FY guidance calls for a 1.8% decline. This follows a 3-year CAGR of 2.1% in revenue, with operating income growth at 0.7% CAGR. The slowdown in growth correlates with capital expenditures outpacing operating cash flow. Risk assessment highlights liquidity as the primary concern. The company's negative net cash position and negative free cash flow create medium liquidity risk. Dilution risk is assessed as low, with no recent share issuance and diluted shares outstanding equal to basic shares. However, the capital structure adjustment for free cash flow includes a -15% downward revision for working capital needs. Recent filings show no material changes in business strategy or risk profile. The 2023 annual report confirms continued focus on core chemical products and no new material commitments. Transcripts from Q1 2024 earnings calls emphasize cost control measures to offset raw material price volatility.
Key takeaways
  • Conservative debt structure with debt-to-equity of 0.23, but negative net cash position creates liquidity risk
  • Underperforming profitability metrics with ROE of 5.07% vs. 8.2% industry median
  • Revenue concentration in South Korea (98%) and carbon dioxide gas segment (52%) increases geographic and product risk
  • Growth trajectory shows deceleration with next FY revenue guidance at -1.8% despite 4.2% current FY growth
  • --
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$61.35B
Gross profit$15.87B
Operating income$2.08B
Net income$8.75B
R&D
SG&A
D&A
SBC
Operating cash flow$7.19B
CapEx-$15.02B
Free cash flow-$5.84B
Total assets$224.43B
Total liabilities$51.87B
Total equity$172.56B
Cash & equivalents$10.00B
Long-term debt$40.29B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$172.56B
Net cash-$30.29B
Current ratio4.9
Debt/Equity0.2
ROA3.9%
ROE5.1%
Cash conversion82.0%
CapEx/Revenue-24.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric006890Activity
Op margin3.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin14.3%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin25.9%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-24.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity23.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:47 UTC#b7663aa9
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:50 UTCJob: 86097ae4